Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report

BACKGROUND: Malignant pleural mesothelioma has limited therapeutic options and a poor outcome. Antiangiogenic agents might increase the efficacy of immunotherapy as second-line treatment of advanced-stage malignancies. CASE SUMMARY: A patient with stage IIIB pleural mesothelioma received second-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Xuan, Tian-Tian, Li, Guang-Yi, Meng, Si-Bo, Wang, Zhan-Mei, Qu, Lin-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403696/
https://www.ncbi.nlm.nih.gov/pubmed/36159517
http://dx.doi.org/10.12998/wjcc.v10.i23.8284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403696/
https://www.ncbi.nlm.nih.gov/pubmed/36159517
http://dx.doi.org/10.12998/wjcc.v10.i23.8284

Ejemplares similares